INDICATIONS AND USAGE
ESBRIET is a pyridone indicated for the treatment of idiopathic pulmonary fibrosis (IPF).
DOSAGE FORMS & STRENGTHS
• Capsules: 267 mg
• Tablets: 267 mg, 801 mg
Manufactured By: Genentech
Prescribing Information URL: Click Here
FDA approved Anti-Cancer medicine ESBRIET (pirfenidone) capsules is available upon request. To get best retail price of ESBRIET (pirfenidone) capsules India, For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email [email protected] For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with pulmonologist.
Pirfenidone is a medication used for the treatment of idiopathic pulmonary fibrosis. It works by reducing lung fibrosis through downregulation of the production of growth factors and procollagens I and II.
It was first approved in Japan for the treatment of patients with idiopathic pulmonary fibrosis after clinical trials, under the trade name of Pirespa by Shionogi, in 2008. It was approved for use in the European Union in 2011, in Canada in 2012, and in the United States in October 2014. There is also a topical form created for the treatment of abnormal wound healing processes.
You can order pirfenidone capsules through Medvitaz Pharma Solutions under Named Patient Program (NPP). Medvitaz provides patients and physicians access to commercialy approved medicines that are not available to them in their own country. Medvitaz objectives is to make quality medicines available at affordable prices for patients and physicians. To get best retail price/cost of pirfenidone capsules in India, Call 8750295029 or Email [email protected]. FDA approved drugs of Australia, Canada, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA.
Head of Operations
The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.
Contact us and we will reply as soon as possible!
MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.
